Sinopharm Vaccine Approved to Treat Children, Teenagers
Sinopharm's COVID-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.
The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the COVID-19 pandemic.
It is the second domestic COVID-19 vaccine made available for children and teenagers in China. In June, Sinovac Biotech's vaccine was authorized for emergency use ...